Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Low muscle tone (hypotonia) and Profound global developmental delay; and common findings: Oligohydramnios, Polyhydramnios, Absent speech, and Atypical absence seizure and others. 21 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Hyporeflexia, Absent speech, Generalized-onset seizure |
SZT2 function has not been fully characterized.
Developmental and epileptic encephalopathy, 18 is associated with mutations in the SZT2 gene on chromosome 1.
Genetic testing for SZT2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 8 common features.
No clinical trials have been registered for developmental and epileptic encephalopathy, 18.
31 publications have been identified in PubMed for developmental and epileptic encephalopathy, 18. Research spans Review / Meta-Analysis (26%), Basic Science / Preclinical (26%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 26% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Heart and blood vessels |
2 |
Aortic regurgitation, Atrial septal defect |
Muscles | 1 | Low muscle tone (hypotonia) |
Eyes | 1 | Ptosis |
Age of onset: infancy.
Laboratory research
8 |
26% |
Disease patterns and progression | 7 | 23% |
Patient case studies | 5 | 16% |
Clinical study results | 3 | 10% |
Chen H (2026). [PMID: 42148092](https://pubmed.ncbi.nlm.nih.gov/42148092/). *Front Immunol*. [Basic Science / Preclinical]
Singh A (2026). [PMID: 41347602](https://pubmed.ncbi.nlm.nih.gov/41347602/). *Epilepsia Open*. [Review / Meta-Analysis]
Vikin T (2026). [PMID: 41066145](https://pubmed.ncbi.nlm.nih.gov/41066145/). *Epilepsia*. [Epidemiology / Natural History]
Perulli M (2026). [PMID: 41677102](https://pubmed.ncbi.nlm.nih.gov/41677102/). *Epilepsia Open*. [Clinical Trial Publication]
Kansal B (2026). [PMID: 41498396](https://pubmed.ncbi.nlm.nih.gov/41498396/). *Mov Disord Clin Pract*. [Clinical Trial Publication]
Lee HA (2026). [PMID: 41643417](https://pubmed.ncbi.nlm.nih.gov/41643417/). *Seizure*. [Review / Meta-Analysis]
Zhang X (2026). [PMID: 42064984](https://pubmed.ncbi.nlm.nih.gov/42064984/). *Front Neurol*. [Basic Science / Preclinical]
McPherson TO (2026). [PMID: 41904855](https://pubmed.ncbi.nlm.nih.gov/41904855/). *Pediatr Neurol*. [Clinical Trial Publication]
Qi L (2026). [PMID: 41560101](https://pubmed.ncbi.nlm.nih.gov/41560101/). *Medicine (Baltimore)*. [Case Report / Case Series]
Sato E (2026). [PMID: 41535455](https://pubmed.ncbi.nlm.nih.gov/41535455/). *Sci Rep*. [Basic Science / Preclinical]